The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Low CD4+T Cell Count Is a Risk Factor for Cardiovascular Disease Events in the HIV Outpatient Study
Abstract
BACKGROUND: Traditional cardiovascular disease (CVD) risk factors, human immunodeficiency virus (HIV) infection, and antiretroviral (ARV) agents have been associated with CVD events in HIV-infected patients. We investigated the association of low CD4(+) T lymphocyte cell count with incident CVD in a cohort of outpatients treated in 10 HIV specialty clinics in the United States. METHODS: We studied patients who were under observation from 1 January 2002 (baseline), categorized them according to National Cholesterol Education Program guidelines into 10-year cardiovascular risk score (10-y CVR) groups , and observed them until CVD event, death, last HIV Outpatient Study contact, or 30 September 2009. We calculated rates of incident CVD events and identified associated baseline risk factors using Cox proportional hazard models. We also performed a nested case-control study to examine the association of latest CD4(+) cell count with CVD events. RESULTS: Among 2005 patients, 148 experienced incident CVD events. CVD incidence increased steadily from 0.4 to 3.0 events per 100 person-years from lowest to highest 10-y CVR group (P < .001). In multivariable Cox analyses adjusted for 10-y CVR, CD4(+) cell count <350 cells/mm(3) was associated with incident CVD events (hazard ratio, 1.58 [95% confidence interval, 1.09-2.30], compared with >500 cells/mm(3)), suggesting an attributable risk of approximately 20%. In the multivariable case-control analyses, traditional CVD risk factors and latest CD4(+) cell count <500 cells/mm(3), but not cumulative use of ARV class or individual drugs, were associated with higher odds of experiencing CVD events. CONCLUSION: CD4(+) count <500 cells/mm(3) is an independent risk factor for incident CVD, comparable in attributable risk to several traditional CVD risk factors in the HIV Outpatient Study cohort.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Triant, V. A., Lee, H., Hadigan, C., & Grinspoon, S. K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2190 · Cited by 1,613
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323
Methods in Observational Epidemiology
Kelsey, J. L. (1986) · Cited by 1,307
Impact of HIV infection and HAART on serum lipids in men
Riddler, S. A. (2003) · JAMA · doi:10.1001/jama.289.22.2978 · Cited by 624
Mary-Krause, M., Cotte, L., Simon, A., Partisani, M., & Costagliola, D. (2003) · AIDS · doi:10.1097/00002030-200311210-00010 · Cited by 564
Coronary Heart Disease in HIV-Infected Individuals
Currier, J. S., Taylor, A., Boyd, F., Dezii, C. M., Kawabata, H., Burtcel, B., Maa, J.-F., & Hodder, S. (2003) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200308010-00012 · Cited by 537
Mulligan, K., Grunfeld, C., Tai, V. W., Algren, H., Pang, M., Chernoff, D. N., Lo, J. C., & Schambelan, M. (2000) · Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00042560-200001010-00005 · Cited by 518
Severe premature coronary artery disease with protease inhibitors
Henry, K., Melroe, H., Huebsch, J., Hermundson, J., Levine, C., Swensen, L., & Daley, J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79053-x · Cited by 513
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
Holmberg, S. D., Moorman, A. C., Williamson, J. M., Tong, T. C., Ward, D. J., Wood, K. C., Greenberg, A. E., & Janssen, R. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11672-2 · Cited by 488
Self-citationSaves, M., Chene, G., Ducimetiere, P., Leport, C., Le Moal, G., Amouyel, P., Arveiler, D., Ruidavets, J.-B., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 400
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/586713 · Cited by 399
Eron, J., Yeni, P., Gathe, J., Estrada, V., DeJesus, E., Staszewski, S., Lackey, P., Katlama, C., Young, B., Yau, L., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69155-1 · Cited by 344
Grunfeld, C., Delaney, J. A., Wanke, C., Currier, J. S., Scherzer, R., Biggs, M. L., Tien, P. C., Shlipak, M. G., Sidney, S., Polak, J. F., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832d3b85 · Cited by 309
El‐Sadr, W., Mullin, C., Carr, A., Gibert, C., Rappoport, C., Visnegarwala, F., Grunfeld, C., & Raghavan, S. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00273.x · Cited by 284
Johnson, M., Grinsztejn, B., Rodriguez, C., Coco, J., DeJesus, E., Lazzarin, A., Lichtenstein, K., Rightmire, A., Sankoh, S., & Wilber, R. (2005) · AIDS · doi:10.1097/01.aids.0000166091.39317.99 · Cited by 248
Self-citationTen-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women
Kaplan, R. C., Kingsley, L. A., Sharrett, A. R., Li, X., Lazar, J., Tien, P. C., Mack, W. J., Cohen, M. H., Jacobson, L., & Gange, S. J. (2007) · Clinical Infectious Diseases · doi:10.1086/521935 · Cited by 220
Endothelial Function in HIV-Infected Persons
Solages, A., Vita, J. A., Thornton, D. J., Murray, J., Heeren, T., Craven, D. E., & Horsburgh, C. R. (2006) · Clinical Infectious Diseases · doi:10.1086/503261 · Cited by 208
Wand, H., Calmy, A., Carey, D. L., Samaras, K., Carr, A., Law, M. G., Cooper, D. A., & Emery, S. (2007) · AIDS · doi:10.1097/qad.0b013e3282efad32 · Cited by 195
Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors
Grunfeld, C., Kotler, D. P., Arnett, D. K., Falutz, J. M., Haffner, S. M., Hruz, P., Masur, H., Meigs, J. B., Mulligan, K., Reiss, P., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189623 · Cited by 178
Currier, J. S., Kendall, M. A., Zackin, R., Henry, W. K., Alston-Smith, B., Torriani, F. J., Schouten, J., Mickelberg, K., Li, Y., & Hodis, H. N. (2005) · AIDS · doi:10.1097/01.aids.0000171406.53737.f9 · Cited by 176
Effects of HIV Infection and Antiretroviral Therapy on the Heart and Vasculature
Dubé, M. P., Lipshultz, S. E., Fichtenbaum, C. J., Greenberg, R. N., Schecter, A. D., Fisher, S. D., & for Working Group 3 (2008) · Circulation · doi:10.1161/circulationaha.107.189625 · Cited by 132
Potteaux, S., Combadière, C., Esposito, B., Lécureuil, C., Ait‐Oufella, H., Merval, R., Ardouin, P., Tedgui, A., & Mallat, Z. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000231527.22762.71 · Cited by 122
Bursill, C. A., Channon, K. M., & Greaves, D. R. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00007 · Cited by 102
Sobieszczyk, M. E., Hoover, D. R., Anastos, K., Mulligan, K. M., Tan, T., Shi, Q., Gao, W., Hyman, C. L., Cohen, M. H., Cole, S. R., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817af461 · Cited by 95
Cockerham, L. R., Scherzer, R., Zolopa, A. R., Rimland, D., Lewis, C. E., Bacchetti, P., Grünfeld, C., Shlipak, M. G., & Tien, P. C. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b79d22 · Cited by 85
Martínez, E., Domingo, P., Galindo, M. J., Milinkovic, A., Arroyo, J. A., Baldoví, F., Larrousse, M., León, A., de Lazzari, E., & Gatell, J. M. (2004) · Clinical Infectious Diseases · doi:10.1086/382531 · Cited by 82
Montes, M., Pulido, F., Barrós, C., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki063 · Cited by 81
Lai, S., Fishman, E. K., Lai, H. C., Moore, R. D., Cofrancesco, J., Pannu, H. K., Tong, W., Du, J., & Bartlett, J. (2008) · Clinical Infectious Diseases · doi:10.1086/526782 · Cited by 45
Lopinavir‐Ritonavir: Effects on Endothelial Cell Function in Healthy Subjects
Grubb, J. R., Dejam, A., Voell, J., Blackwelder, W. C., Sklar, P. A., Kovacs, J. A., Cannon, R. O., Masur, H., & Gladwin, M. T. (2006) · The Journal of Infectious Diseases · doi:10.1086/503807 · Cited by 31
Cited by
The end of AIDS: HIV infection as a chronic disease
Deeks, S. G., Lewin, S. R., & Havlir, D. V. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61809-7 · Cited by 2,063
HIV Infection and the Risk of Acute Myocardial Infarction
Freiberg, M. S., Chang, C.-C. H., Kuller, L. H., Skanderson, M., Lowy, E., Kraemer, K. L., Butt, A. A., Bidwell Goetz, M., Leaf, D., Oursler, K. A., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3728 · Cited by 1,340
Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., Post, W. S., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 658
Deeks, S. G., Overbaugh, J., Phillips, A., & Buchbinder, S. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 644
Islam, F., Wu, J., Jansson, J., & Wilson, D. (2012) · HIV Medicine · doi:10.1111/j.1468-1293.2012.00996.x · Cited by 432
Metadata
- Authors
- Lichtenstein, K. A., Armon, C., Buchacz, K., Chmiel, J. S., Buckner, K., Tedaldi, E. M., Wood, K., Holmberg, S. D., & Brooks, J. T.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-08-15
- Volume
- 51
- Issue
- 4
- Pages
- 435-447
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2166535756
- Cited by
- 296
- References
- 38
- FWCI
- 25.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.